Good news for those over the age of 55. Moderna’s coronavirus vaccine candidate showed a strong immune response in older adults in a recent clinical trial.
Two months after receiving the vaccine, 20 study participants had higher antibody levels than people recovering from COVID-19. Previous early trials of the would-be vaccine showed equally promising results for a younger population.
According to Politico, Moderna presented their research findings to the Centers for Disease Control and Prevention in a meeting Wednesday. Experts say it is important to ensure a vaccine works for both young adults and seniors because the immune system’s ability to fight infections declines with age.
Read more at NEWSMAX.